4//SEC Filing
ROBINS HARLAN S 4
Accession 0001062993-25-008509
CIK 0001478320other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:27 PM ET
Size
9.0 KB
Accession
0001062993-25-008509
Insider Transaction Report
Form 4
ROBINS HARLAN S
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2025-05-01$6.32/sh+68,412$432,364→ 1,347,936 total - Sale
Common Stock
2025-05-01$7.35/sh−68,412$502,828→ 1,279,524 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-05-01−68,412→ 0 totalExercise: $6.32Exp: 2025-06-09→ Common Stock (68,412 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024. The option would have expired on June 9, 2025.
- [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.18 to 7.51, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- [F3]The option was fully vested and exercisable.
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780851
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:27 PM ET
- Size
- 9.0 KB